nectin 2 pe (Miltenyi Biotec)
Structured Review

Nectin 2 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd112/CD112+Antibody%2C+anti-human%2C+REAfinity/pmc12901471-67-27-33
Average 94 stars, based on 7 article reviews
Images
1) Product Images from "Osteoclasts affect the anti-cancer activity of NK cells"
Article Title: Osteoclasts affect the anti-cancer activity of NK cells
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2026.1730283
Figure Legend Snippet: Expression of NK cell receptor ligands by OCs by flow cytometry. The graph shows the expression levels of PVR and Nectin-2, respectively ligands of DNAM-1 and TIGIT on OCs and on OC+NK cells after 3 days (A) . Characterization of NID-1 ligand of NKp44 and B7H6 ligand of NKp30 on OCs and on OCs+NK cells, with A549s and with both NK cells+A549s (B) . N = 6 experiments. Groups were compared using a one-way repeated measures analysis of variance with post hoc Tukey test (* p < 0.05; ** p < 0.01).
Techniques Used: Expressing, Flow Cytometry
Figure Legend Snippet: Analysis of CD133 + /CXCR4 + CSC subset. Evaluation of the CSC CD133 + /CXCR4 + subset of A549s, in co-culture with NK cells, OCs and with both OCs and NK cells (A) . Evaluation of expression levels of Nectin-2 (ligand of TIGIT and DNAM-1) (B) and Nectin-4 (ligand of TIGIT) (C) on CD133 + cells, in co-culture with NK cells, OCs and with NK cells+OCs (B, C) . N = 5 experiments. Groups were compared using a one-way repeated measures analysis of variance with post hoc Tukey test (* p < 0.05; ** p < 0.01).
Techniques Used: Co-Culture Assay, Expressing
Related Articles
Flow Cytometry:Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% Penicillin-Streptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% PenicillinStreptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Staining:Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% Penicillin-Streptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Article Title: CD94-driven in vitro expansion of highly functional adaptive NKG2C + NKG2A - CD57 + NK cells from CMV + healthy donors Article Snippet: .. CD3 VioGreen REA613 Miltenyi Biotec CD3 PerCP-Cy5.5 UCHT1 BD Biosciences CD3z PE 6B10.2 eBioscience Inc. CD14 VioGreen/APC REA599 Miltenyi Biotec CD16 PerCP-Cy5.5 3G8 BD Biosciences CD19 VioGreen/VioBlue REA675 Miltenyi Biotec CD33 VioGreen REA775 Miltenyi Biotec CD34 APC QBEnd10 R&D Systems CD34 PE QBEnd10 Beckman Coulter CD48 - CO202 Produced in our laboratory CD56 PC7 N901 Beckman Coulter CD56 - C218 Produced in our laboratory CD57 VioBlue TB03 Miltenyi Biotec CD107a (LAMP1) PE/APC-H7 H4A3 BD Biosciences FcεRI-γ FITC Polyclonal Merck Millipore Fixable Viability Stain BV510 - BD Biosciences Granzyme B PE GB12 Invitrogen Goat anti-mouse IgG1 PE Polyclonal SouthernBiotech Goat anti-mouse IgG2b PE/APC-Cy7 Polyclonal SouthernBiotech HLA-E - 3D12 Abnova HLA-DR - D1.12 Produced in our laboratory HLA-G - MEM-G/9 Abnova HLA-I - W6/32 Produced in our laboratory IFN-γ APC/PE B27 BD Biosciences KIR2DL1/S1-2DL3*005 FITC/APC 11PB6 Miltenyi Biotec KIR2DL1/S5 FITC/APC/PE 143211 R&D Systems KIR2DL2/L3/S2 APC DX27 Miltenyi Biotec KIR2DL2/L3/S2 FITC CH-L BD Biosciences KIR2DL2/L3/S2 PE GL183 Beckman Coulter KIR3DL1 FITC DX9 Miltenyi Biotec LAG-3 APC REA351 Miltenyi Biotec LFA-3 - TS2/9 Produced in our laboratory MIC-A - BAM195 Kindly provided by Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% PenicillinStreptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Bioprocessing:Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% Penicillin-Streptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Article Title: Osteoclasts affect the anti-cancer activity of NK cells Article Snippet: To obtain CSCs (A549s), A549 cells were detached by Tripsin (Euroclone, Pero, Milano), counted and plated at 10.000 cells/well in Ultra-Low Attachment 6-multi-well (Thermo Fisher Scientific, Carlsbad, CA, USA), in a serum-free stem cell medium (SCM), constituted by DMEM/F12K (Gibco, Billings, MT, USA), supplemented with B27 (Gibco, Billings, MT, USA), EGF 20 ng/mL (Sigma Aldrich, Burlington, MA, USA), bFGF10 ng/mL (PeproTech, East Windsor, NJ, USA), Heparin 2 g/mL (Stemcell Technologies, Vancouver, Canada), and 1% PenicillinStreptomycin. .. After 10 days, spheroid-like structures were originated, then dissociated by ACCUTASE and analyzed by flow cytometry through the staining with the following anti-human monoclonal antibodies CD133 PE-Vio770, Produced:Article Title: CD94-driven in vitro expansion of highly functional adaptive NKG2C + NKG2A - CD57 + NK cells from CMV + healthy donors Article Snippet: .. CD3 VioGreen REA613 Miltenyi Biotec CD3 PerCP-Cy5.5 UCHT1 BD Biosciences CD3z PE 6B10.2 eBioscience Inc. CD14 VioGreen/APC REA599 Miltenyi Biotec CD16 PerCP-Cy5.5 3G8 BD Biosciences CD19 VioGreen/VioBlue REA675 Miltenyi Biotec CD33 VioGreen REA775 Miltenyi Biotec CD34 APC QBEnd10 R&D Systems CD34 PE QBEnd10 Beckman Coulter CD48 - CO202 Produced in our laboratory CD56 PC7 N901 Beckman Coulter CD56 - C218 Produced in our laboratory CD57 VioBlue TB03 Miltenyi Biotec CD107a (LAMP1) PE/APC-H7 H4A3 BD Biosciences FcεRI-γ FITC Polyclonal Merck Millipore Fixable Viability Stain BV510 - BD Biosciences Granzyme B PE GB12 Invitrogen Goat anti-mouse IgG1 PE Polyclonal SouthernBiotech Goat anti-mouse IgG2b PE/APC-Cy7 Polyclonal SouthernBiotech HLA-E - 3D12 Abnova HLA-DR - D1.12 Produced in our laboratory HLA-G - MEM-G/9 Abnova HLA-I - W6/32 Produced in our laboratory IFN-γ APC/PE B27 BD Biosciences KIR2DL1/S1-2DL3*005 FITC/APC 11PB6 Miltenyi Biotec KIR2DL1/S5 FITC/APC/PE 143211 R&D Systems KIR2DL2/L3/S2 APC DX27 Miltenyi Biotec KIR2DL2/L3/S2 FITC CH-L BD Biosciences KIR2DL2/L3/S2 PE GL183 Beckman Coulter KIR3DL1 FITC DX9 Miltenyi Biotec LAG-3 APC REA351 Miltenyi Biotec LFA-3 - TS2/9 Produced in our laboratory MIC-A - BAM195 Kindly provided by CRISPR:Article Title: Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function Article Snippet: The cells were cultured in IMDM (Gibco) supplemented with FBS (20%), 2-mercaptoethanol (0.08%), and penicillin-streptomycin (1%). .. For CD155 and CD112 KO variants, deletion of PVR and/or Selection:Article Title: Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function Article Snippet: The cells were cultured in IMDM (Gibco) supplemented with FBS (20%), 2-mercaptoethanol (0.08%), and penicillin-streptomycin (1%). .. For CD155 and CD112 KO variants, deletion of PVR and/or other:Article Title: Contrasting Impacts of Targeted Disruption of the Cancer Stem Cell Marker CD133 and Its Epigenetic Regulator TRIM28 in Colorectal Cancer Cells Article Snippet: 12 , Diagnostic Assay:Article Title: Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Article Snippet: .. Original Articles Colorectal cancer-associated fibroblasts inhibit effector T cells via Imaging:Article Title: Colorectal cancer-associated fibroblasts inhibit effector T cells via NECTIN2 signaling. Article Snippet: .. Original Articles Colorectal cancer-associated fibroblasts inhibit effector T cells via |